PMC7780311_01
Patient at baseline prior to acne therapy with clindamycin phosphate and benzoyl peroxide gel 1.2%/3.75% and tretinoin microsphere 0.06% gel.
10.1177_2050313X20984038-fig1.jpg
PMC7780311_01_10.1177_2050313X20984038-fig1.jpg
fig1-2050313X20984038
A 29-year-old Asian American transgender female presented with a 15-year history of recurrent red facial acne and scarring (Figure 1).
2 months after therapy with clindamycin phosphate and benzoyl peroxide gel 1.2%/3.75% and tretinoin microsphere 0.06% gel.
10.1177_2050313X20984038-fig2.jpg
PMC7780311_01_10.1177_2050313X20984038-fig2.jpg
fig2-2050313X20984038
At her 2-month follow-up appointment, her acne had decreased to an EGSS of 1 (almost clear) and acne scaring to a severity grading scale of 2 (mild) (Figure 2).